Intervention Review

Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients

  1. Lior H Katz1,*,
  2. Hadar Goldvaser2,
  3. Anat Gafter-Gvili3,
  4. Ran Tur-Kaspa4

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 12 SEP 2012

Assessed as up-to-date: 16 JAN 2012

DOI: 10.1002/14651858.CD008516.pub2


How to Cite

Katz LH, Goldvaser H, Gafter-Gvili A, Tur-Kaspa R. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD008516. DOI: 10.1002/14651858.CD008516.pub2.

Author Information

  1. 1

    MD Anderdson Cancer Center, Hepatology and Nutrition Department, Houston, Texas, USA

  2. 2

    Beilinson Hospital, Rabin Medical Center, Department of Oncology, Petah Tikva, Israel

  3. 3

    Beilinson Hospital, Rabin Medical Center, Department of Medicine E, Petah Tikva, Israel

  4. 4

    Beilinson Hospital, Rabin Medical Center, Department of Medicine D, Petah Tikva, Israel

*Lior H Katz, Hepatology and Nutrition Department, MD Anderdson Cancer Center, 1515 Holcombe st., Houston, Texas, 77030, USA. liorshlomit@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 12 SEP 2012

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.